Sand Hill Global Advisors, LLC Abbott Laboratories Transaction History

Sand Hill Global Advisors, LLC

$2.37 Billion
Q3 2024

A detailed history of Sand Hill Global Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Sand Hill Global Advisors, LLC holds 64,753 shares of ABT stock, worth $7.5 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

64,753

Previous 67,648 4.28%

Holding current value

$7.5 Million

Previous $7.03 Million 5.02%

% of portfolio

0.31%

Previous 0.32%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $289,702 - $341,986	-2,895 Reduced 4.28%	64,753 $7.38 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $48,148 - $53,746	-478 Reduced 0.7%	67,648 $7.03 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $114,448 - $126,403	-1,045 Reduced 1.51%	68,126 $7.74 Million
Q4 2023 Feb 09, 2024	BUY	$90.19 - $110.4 $49,604 - $60,720	550 Added 0.8%	69,171 $7.61 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $24,551 - $29,457	257 Added 0.38%	68,621 $6.65 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $1.03 Million - $1.15 Million	-10,263 Reduced 13.05%	68,364 $7.45 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $60,828 - $71,598	628 Added 0.81%	78,627 $7.96 Million
Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $914,572 - $1.07 Million	9,621 Added 14.07%	77,999 $8.57 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $90,470 - $104,748	-935 Reduced 1.35%	68,378 $6.62 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $302,535 - $365,668	2,964 Added 4.47%	69,313 $7.53 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $120,633 - $147,104	1,058 Added 1.62%	66,349 $7.85 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $33,388 - $40,881	-289 Reduced 0.44%	65,291 $9.19 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $216,404 - $239,406	-1,855 Reduced 2.75%	65,580 $7.75 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $204,915 - $241,214	1,937 Added 2.96%	67,435 $7.82 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $435,033 - $512,535	-3,997 Reduced 5.75%	65,498 $7.85 Million
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $140,280 - $152,865	-1,336 Reduced 1.89%	69,495 $7.61 Million
Q3 2020 Nov 10, 2020	SELL	$91.64 - $111.29 $120,231 - $146,012	-1,312 Reduced 1.82%	70,831 $7.71 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $290,812 - $372,204	-3,798 Reduced 5.0%	72,143 $6.6 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $65,395 - $95,626	1,041 Added 1.39%	75,941 $5.99 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $682,408 - $759,680	8,692 Added 13.13%	74,900 $6.51 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $173,337 - $187,951	-2,118 Reduced 3.1%	66,208 $5.54 Million
Q2 2019 Aug 13, 2019	SELL	$72.88 - $85.0 $113,401 - $132,260	-1,556 Reduced 2.23%	68,326 $5.75 Million
Q1 2019 May 03, 2019	SELL	$66.22 - $80.06 $148,001 - $178,934	-2,235 Reduced 3.1%	69,882 $5.59 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $131,447 - $148,911	-2,005 Reduced 2.7%	72,117 $5.22 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $103,620 - $125,005	-1,704 Reduced 2.25%	74,122 $5.44 Million
Q2 2018 Aug 10, 2018	BUY	$57.57 - $63.54 $3.73 Million - $4.12 Million	64,820 Added 588.95%	75,826 $4.63 Million
Q1 2018 May 10, 2018	SELL	$56.27 - $63.62 $3.74 Million - $4.23 Million	-66,444 Reduced 85.79%	11,006 $659,000
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $28,235 - $30,229	-526 Reduced 0.67%	77,450 $4.42 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $3.75 Million - $4.18 Million	77,976	77,976 $4.16 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sand Hill Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sand Hill Global Advisors, LLC with notifications on news.

Account

Sand Hill Global Advisors, LLC Abbott Laboratories Transaction History